Kura Oncology, Inc.
DE ˙ DB ˙ US50127T1097
7,56 € ↑0,24 (3,28%)
2026-06-05
PREZZO DELLE AZIONI
SecurityDE:KUR / Kura Oncology, Inc.
InstitutionFranklin Resources Inc
Latest Disclosed Ownership14,353 shares
Latest Disclosed Value $ 116,689
Franklin Resources Inc reports 94.89% decrease in ownership of KUR / Kura Oncology, Inc.

On May 13, 2026 - Franklin Resources Inc filed a 13F-HR form disclosing ownership of 14,353 shares of Kura Oncology, Inc. (DE:KUR) valued at $95,447 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 281,115 shares of Kura Oncology, Inc.. This represents a change in shares of -94.89% during the quarter. The current value of the position is $108,509 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F KURA ONCOLOGY COM 50127T109 14,353 -266,762 -94.89 117 -96.03 0.0000
2026-02-11 2025-12-31 13F KURA ONCOLOGY COM 50127T109 281,115 52,671 23.06 2,921 44.48 0.0007
2025-11-13 2025-09-30 13F KURA ONCOLOGY COM 50127T109 228,444 -73,970 -24.46 2,022 15.88 0.0005
2025-08-12 2025-06-30 13F KURA ONCOLOGY COM 50127T109 302,414 -1,262,452 -80.67 1,745 -83.11 0.0005
2025-05-13 2025-03-31 13F KURA ONCOLOGY COM 50127T109 1,564,866 26,274 1.71 10,328 -22.93 0.0030
2025-02-12 2024-12-31 13F KURA ONCOLOGY COM 50127T109 1,538,592 -49,809 -3.14 13,401 -53.28 0.0037
2024-11-27 2024-09-30 13F/A-1 KURA ONCOLOGY COM 50127T109 1,588,401 23,113 1.48 28,687 -10.99 0.0081
2024-11-12 2024-09-30 13F KURA ONCOLOGY COM 50127T109 1,588,401 23,113 28,687 0.0014
2024-08-14 2024-06-30 13F KURA ONCOLOGY COM 50127T109 1,565,288 -9,958 -0.63 32,229 -4.08 0.0099
2024-05-13 2024-03-31 13F KURA ONCOLOGY COM 50127T109 1,575,246 221,581 16.37 33,600 72.61 0.0106
2024-02-09 2023-12-31 13F KURA ONCOLOGY COM 50127T109 1,353,665 130,710 10.69 19,466 74.53 0.0091
2023-11-13 2023-09-30 13F KURA ONCOLOGY COM 50127T109 1,222,955 -1,542 -0.13 11,153 -13.91 0.0057
2023-08-11 2023-06-30 13F KURA ONCOLOGY COM 50127T109 1,224,497 32,821 2.75 12,955 -11.11 0.0062
2023-05-12 2023-03-31 13F KURA ONCOLOGY COM 50127T109 1,191,676 126,416 11.87 14,574 10.25 0.0073
2023-02-10 2022-12-31 13F KURA ONCOLOGY COM 50127T109 1,065,260 430,595 67.85 13,220 52.47 0.0069
2022-11-14 2022-09-30 13F KURA ONCOLOGY COM 50127T109 634,665 7,542 1.20 8,670 -24.58 0.0047
2022-08-11 2022-06-30 13F KURA ONCOLOGY COM 50127T109 627,123 1,229 0.20 11,496 14.23 0.0057
2022-05-13 2022-03-31 13F KURA ONCOLOGY COM 50127T109 625,894 -349,028 -35.80 10,064 -26.27 0.0040
2022-02-11 2021-12-31 13F KURA ONCOLOGY COM 50127T109 974,922 -3,533 -0.36 13,649 -25.52 0.0049
2021-11-12 2021-09-30 13F KURA ONCOLOGY COM 50127T109 978,455 -2,423 -0.25 18,326 -10.39 0.0069
2021-08-13 2021-06-30 13F KURA ONCOLOGY COM 50127T109 980,878 239,114 32.24 20,451 -2.47 0.0078
2021-05-13 2021-03-31 13F KURA ONCOLOGY COM 50127T109 741,764 240,144 47.87 20,970 28.00 0.0085
2021-02-10 2020-12-31 13F KURA ONCOLOGY COM 50127T109 501,620 501,620 16,383 0.0069
2016-08-11 2016-06-30 13F KURA ONCOLOGY COM 50127T109 0 -730,500 -100.00 0 -100.00
2016-05-10 2016-03-31 13F KURA ONCOLOGY COM 50127T109 730,500 -239,671 -24.70 2,959 -63.69 0.0016
2016-04-27 2015-12-31 13F/A-1 KURA ONCOLOGY COM 50127T109 970,171 970,171 8,149 0.0041
2016-02-12 2015-12-31 13F KURA ONCOLOGY COM 50127T109 970,171 8,149 0.0041
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.